Model
Edge
Acrivon Therapeutics Inc.
0001792061
Filing Type
4
Filing Date
6/16/2025
Updated
6/17/25, 4:04 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership